Randox Quality Control Launches Acusera Anti-Müllerian Hormone (AMH) Control
Posted on 08 Jun 2022
Randox (Crumlin, UK) has launched a new Acusera Control for the accurate and reliable testing of Anti-Müllerian Hormone (AMH).
An AMH test is often used to check a woman’s ability to produce eggs that can be fertilized for pregnancy, thus helping women to make informed decisions about their health. The new Randox Acusera AMH control is designed for use as a third-party control for the quantitative determination of AMH. Available in a liquid frozen format for convenience and reduced handling errors, the control should be treated in the same manner as a patient sample.
The Acusera AMH is a true third-party control providing an unbiased assessment of performance and is manufactured using human serum, ensuring commutable sample matrix. It provides assayed target values, thus eliminating the need to assign values in-house. The control is available at recommended cut-off values for AMH and has 30-day stability when stored at +2°C to +8°C.
Related Links:
Randox
